Skip to content

Celcuity CELC Debt Issuance Cost Amortization

Debt Issuance Cost Amortization at other companies

BridgeBio Pharma logo
BridgeBio PharmaBBIO
$1.82M+12.2%
Cogent Biosciences, Inc. logo
Cogent Biosciences, Inc.COGT
$278K
Tenet Healthcare logo
Tenet HealthcareTHC
$5M-16.7%
TG Therapeutics logo
TG TherapeuticsTGTX
$285K-6.3%

Other financials

Income statement

See full
Operating income-$50.5M-39.8%
Net income-$52.8M-42.8%
EPS (diluted)-$0.97-12.8%

Balance sheet

See full
Cash & equivalents$145.2M+781%
Total debt$137.9M+30.7%
Total equity$53.5M-38.2%
Total assets$410.2M+88.0%

Cash flow

See full
Operating cash flow-$55.1M-53.6%
CapEx$249.0K+315%
Free cash flow-$55.3M-54.0%

Valuation

See full
Market cap$4.28B+1,370%
Enterprise value$4.27B+1,086%

Returns & leverage

See full
Return on equity-275.2%-990pp
Debt / equity2.6×+1.4×
Current ratio12.3×+5.7×

Where this comes from

Reported directly by Celcuity in its filing.

Tagged under the XBRL concept us-gaap:AmortizationOfFinancingCostsAndDiscounts.

The official record: Celcuity’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Celcuity's debt issuance cost amortization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Celcuity's debt issuance cost amortization?
Celcuity (CELC) reported debt issuance cost amortization of $1.25M in Q1 2026.
How has Celcuity's debt issuance cost amortization changed year-over-year?
Celcuity's debt issuance cost amortization increased by 127.2% year-over-year, from $551K to $1.25M.
What is the long-term trend for Celcuity's debt issuance cost amortization?
Over 3 years (2022 to 2025), Celcuity's debt issuance cost amortization has grown at a 99.4% compound annual growth rate (CAGR), from $395.76K to $3.14M.
What does debt issuance cost amortization mean?
Non-cash amortization of capitalized costs incurred to issue debt (underwriting fees, legal costs, SEC filing fees).